User Guide,Peptides

The landscape of peptide research and application is constantly evolving, particularly concerning regulatory status. For individuals and organizations involved with peptides, understanding the current list of banned peptides is crucial. Recent regulatory shifts, primarily involving the Food and Drug Administration (FDA) in the United States and the World Anti-Doping Agency (WADA), have impacted the availability and legality of various peptide compounds. This article aims to provide a clear overview of these regulations, including specific peptide hormones and related substances that are subject to restrictions, and the implications for different users.

FDA's Evolving Stance on Peptides

The FDA has historically taken a cautious approach to the marketing and use of unapproved peptides, especially those intended for human consumption or therapeutic purposes outside of strictly controlled research. In late 2023, the FDA initiated a significant reclassification of certain peptide compounds, moving 19 peptides from FDA Category 1 to FDA Category 2. This reclassification, expected to be fully implemented by early 2026, signifies a shift in how these substances are regulated.

While not a complete ban, reclassification to Category 2 often implies that these peptides are considered unapproved for human use and their marketing may be subject to stricter scrutiny. Some of the peptides that have been subject to this reclassification include:

* BPC-157: Often referred to as a healing and regenerative peptide, BPC-157 has garnered attention for its purported tissue repair properties.

* CJC-1295: This is a growth hormone-releasing peptide that has been a subject of interest in performance enhancement circles.

* Ipamorelin: Another growth hormone-releasing peptide (GHRP), Ipamorelin is known for its specific interaction with the pituitary gland.

* Thymosin Alpha-1 (TA-1): An immune-modulating peptide, Thymosin Alpha-1 has been studied for its potential roles in immune system regulation.

* Thymosin Beta 4 (TB4): Similar to Thymosin Alpha-1, TB4 is also recognized for its regenerative and anti-inflammatory properties.

* Epitalon: This synthetic peptide has been associated with potential anti-aging and telomere-lengthening effects.

* AOD-9604: Primarily investigated for its potential in fat loss, AOD-9604 is a fragment of human growth hormone.

* DSIP: Delta-sleep-inducing peptide is known for its potential to influence sleep patterns and relaxation.

* DIHEXA: A newer peptide that has emerged in discussions related to cognitive function and neurological health.

* Selank: Initially made the banned list, Selank is a nootropic peptide that has been explored for its anxiolytic and cognitive-enhancing effects.

* Kisspeptin-10: Used in reproductive health research, Kisspeptin-10 plays a role in the regulation of reproductive hormones.

It is important to note that the FDA's regulatory approach is dynamic. The withdrawal of nominations by some parties has led to certain peptides, like Thymosin Alpha-1 and CJC-1295, being removed from the Category 2 list, indicating a potential easing of restrictions for these specific compounds. The FDA's Category 1 peptide list and Category 2 peptide list are key documents to monitor for the most up-to-date information.

World Anti-Doping Agency (WADA) Prohibited List

For athletes and those involved in competitive sports, adherence to the World Anti-Doping Agency (WADA) Prohibited List is paramount. WADA's regulations prohibit a wide range of substances and methods that can enhance performance or mask the use of other banned substances. Within the WADA framework, peptide hormones and related substances constitute a significant category of prohibited compounds.

The WADA Prohibited List explicitly includes:

* Peptide hormones and related substances: This broad category encompasses substances that stimulate or inhibit the release of hormones, or that mimic their action.

* Human growth hormone (hGH): A naturally occurring hormone that is also synthesized and used illicitly in sports for muscle growth and recovery.

* Insulin-like growth factor-1 (IGF-1): Another potent anabolic agent that promotes tissue growth and repair.

* Erythropoietin (EPO): A hormone that stimulates red blood cell production, enhancing oxygen transport and endurance.

* TB-500: While often discussed in the context of healing, TB-500 (a synthetic version of thymosin beta-4) is also prohibited by WADA due to its performance-enhancing potential.

* GH-releasing peptides (GHRPs):